To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CSPP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
211 supporting clones for gene CSPP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB077553 testis .a 1 to 426 2 to 427   tiling clone, capped   426/426
(100 %)
0 diff
(100 %id)
NM_001077204.1   .a 379 to 4846 1 to 4468   RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4468/4468
(100 %)
0 diff
(100 %id)
DA245734 brain .a 440 to 1030 2 to 593   tiling clone, capped   592/592
(100 %)
2 diff
(99.7 %id)
TI_57202241   .a 443 to 1194 33 to 794   tiling clone,   762/794
(95 %)
19 diff
(97.7 %id)
CR746824 pooled brain, lung, testis .a 444 to 969 1 to 526   tiling clone,   526/526
(100 %)
0 diff
(100 %id)
BI824162 pooled brain, lung, testis .a 444 to 1194 1 to 761   tiling clone,   761/761
(100 %)
15 diff
(98.1 %id)
CN284206 embryonic stem cells, cell lines H1, H7, andH9 .a 877 to 1027 1 to 151       151/151
(100 %)
2 diff
(98.7 %id)
DB306112 brain .a 2435 to 2934 502 to 3   tiling clone,   500/502
(99 %)
4 diff
(99.3 %id)
AM156947 testis .b 1 to 4364 1 to 4364 E830G I880T R930K AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4364/4364
(100 %)
4 diff
(100.0 %id)
BX649147 human adipose .b 1 to 4364 1 to 4365 N913K V914C I915N M916Y E917G ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4365/4365
(100 %)
3 diff
(100.0 %id)
NM_024790.5   .b 2 to 4364 1 to 4363 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4363/4363
(100 %)
0 diff
(100 %id)
BG542694 lung .b 11 to 722 1 to 711   available from MGC,   711/712
(99 %)
19 diff
(97.4 %id)
BC029445 lung .b 12 to 1255 1 to 1242   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1242/1263
(98 %)
6 diff
(99.6 %id)
AA285235   .b 34 to 350 1 to 317       317/330
(96 %)
24 diff
(92.8 %id)
EL735774 mixed .b 141 to 707 1 to 567       567/567
(100 %)
0 diff
(100 %id)
TI_1948220837   .b 141 to 474 140 to 473   fully sequenced,   334/362
(92 %)
6 diff
(98.4 %id)
TI_1948221006   .b 141 to 474 129 to 462   fully sequenced,   334/361
(92 %)
6 diff
(98.4 %id)
TI_1948221179   .b 141 to 474 129 to 462   fully sequenced,   334/361
(92 %)
6 diff
(98.4 %id)
TI_1948221343   .b 141 to 474 127 to 460   fully sequenced,   334/362
(92 %)
6 diff
(98.4 %id)
DN914925   .b 208 to 790 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BG104599 adrenal cortex carcinoma, cell line, adrenal gland .b 213 to 922 1 to 707       707/709
(99 %)
12 diff
(98.4 %id)
TI_1948221180   .b 413 to 759 478 to 132   fully sequenced,   347/381
(91 %)
0 diff
(100 %id)
TI_1948221344   .b 413 to 759 474 to 128   fully sequenced,   347/381
(91 %)
0 diff
(100 %id)
TI_1948220838   .b 424 to 759 468 to 133   fully sequenced,   336/370
(90 %)
0 diff
(100 %id)
TI_1948221007   .b 425 to 759 468 to 134   fully sequenced,   335/369
(90 %)
0 diff
(100 %id)
BM555375 duodenal adenocarcinoma, cell line, small intestine .b 493 to 1461 1 to 976       976/986
(98 %)
15 diff
(98.5 %id)
BG211014   .b 1025 to 1879 861 to 9     Submitted on the opposite strand 855/861
(99 %)
12 diff
(98.7 %id)
BG698003 skin .b 1157 to 1894 1 to 739       739/739
(100 %)
2 diff
(99.8 %id)
R55626 breast .b 1218 to 1687 1 to 479       479/479
(100 %)
16 diff
(96.7 %id)
AA702149 liver and spleen .b 1365 to 1881 515 to 1       515/515
(100 %)
3 diff
(99.5 %id)
BE748025 bone marrow, from acute myelogenous leukemia .b 1369 to 1991 1 to 625       625/854
(73 %)
4 diff
(99.6 %id)
AI760177 pooled .b 1397 to 1883 487 to 1       487/487
(100 %)
0 diff
(100 %id)
W87526 liver and spleen .b 1400 to 1884 491 to 1       491/491
(100 %)
9 diff
(98.2 %id)
DN914926   .b 1424 to 1884 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AL042666.
matches multiple genes
testis .b 1442 to 2107 1 to 668     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS, also hits gene chuty 668/669
(99 %)
4 diff
(99.5 %id)
AA721639 germinal center B cell .b 1527 to 1830 304 to 1       304/304
(100 %)
0 diff
(100 %id)
CN272222 embryonic stem cells, DMSO-treated H9 cellline .b 1563 to 2201 9 to 647       639/647
(98 %)
6 diff
(99.1 %id)
BG217391   .b 1564 to 1879 326 to 10     Submitted on the opposite strand 317/326
(97 %)
15 diff
(95.4 %id)
AA721643 germinal center B cell .b 1584 to 1828 245 to 1       245/245
(100 %)
0 diff
(100 %id)
CB243947 Human Lung Epithelial cells, lung .b 1655 to 2328 675 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 674/684
(98 %)
0 diff
(100 %id)
BF768732 epid_tumor .b 1858 to 2258 438 to 38     Submitted on the opposite strand 401/438
(91 %)
1 diff
(99.8 %id)
R55627 breast .b 1922 to 2382 463 to 1       463/464
(99 %)
4 diff
(99.2 %id)
FN069077 breast carcinoma .b 2005 to 2103 99 to 1     Submitted on the opposite strand 99/99
(100 %)
0 diff
(100 %id)
AI125328   .b 2034 to 2495 460 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 459/460
(99 %)
0 diff
(100 %id)
BX509517   .b 2061 to 2680 1 to 619       619/619
(100 %)
1 diff
(99.9 %id)
BE081056 breast .b 2100 to 2345 254 to 12     Submitted on the opposite strand 243/254
(95 %)
0 diff
(100 %id)
TI_149307779   .b 2165 to 2727 666 to 104       563/1086
(51 %)
0 diff
(100 %id)
BM979496 lung, Primary Lung Epithelial Cells .b 2165 to 2727 584 to 22       563/674
(83 %)
0 diff
(100 %id)
BE720224 head_neck .b 2176 to 2336 166 to 7       160/166
(96 %)
2 diff
(98.8 %id)
BE150669 head_neck .b 2200 to 2659 457 to 1     Submitted on the opposite strand 457/461
(99 %)
15 diff
(96.8 %id)
TI_149271556   .b 2200 to 2931 107 to 834     Submitted on the opposite strand 728/1055
(69 %)
18 diff
(98.3 %id)
BU674496 lung, Primary Lung Epithelial Cells .b 2200 to 2785 35 to 620     Submitted on the opposite strand 586/602
(97 %)
7 diff
(98.9 %id)
AW815919 stomach .b 2257 to 2669 52 to 464       413/579
(71 %)
7 diff
(98.8 %id)
DW415995 Liver .b 2407 to 2676 41 to 311       271/311
(87 %)
8 diff
(97.5 %id)
BC022867 Bone marrow, acute myelogenous leukemia .b 2503 to 4361 1 to 1859   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1859/1860
(99 %)
7 diff
(99.7 %id)
BF242752 bone marrow, from acute myelogenous leukemia .b 2506 to 3068 1 to 574   available from MGC,   574/574
(100 %)
38 diff
(93.4 %id)
TI_1948218106   .b 2544 to 3157 122 to 735   fully sequenced,   614/735
(83 %)
9 diff
(98.8 %id)
TI_1948218447   .b 2544 to 3268 124 to 848   fully sequenced,   725/848
(85 %)
9 diff
(99.0 %id)
CX760497 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2554 to 3238 13 to 699     Submitted on the opposite strand 687/718
(95 %)
18 diff
(97.5 %id)
AK026143   .b 2555 to 3668 1 to 1114   tiling clone, available from FLJ, AAA   1114/1458
(76 %)
2 diff
(99.9 %id)
BP256235 Kidney .b 2555 to 3136 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_1948218274   .b 2558 to 3157 137 to 736   fully sequenced,   600/736
(81 %)
7 diff
(99.1 %id)
TI_1948218612   .b 2558 to 3268 139 to 848   fully sequenced,   710/848
(83 %)
7 diff
(99.2 %id)
EL735366 mixed .b 2559 to 3391 1 to 833       833/833
(100 %)
3 diff
(99.7 %id)
FN126589 breast carcinoma .b 2583 to 2652 75 to 4     Submitted on the opposite strand 72/75
(96 %)
0 diff
(100 %id)
DN911818   .b 2593 to 3236 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
DN916328   .b 2593 to 3164 1 to 571       571/571
(100 %)
2 diff
(99.7 %id)
BF130684 hypernephroma, Kidney .b 2593 to 3162 1 to 571       570/851
(66 %)
15 diff
(98.3 %id)
CN401191 embryonic stem cells, DMSO-treated H9 cellline .b 2661 to 3324 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BE005771 breast_normal .b 2728 to 3456 726 to 10     Submitted on the opposite strand 717/748
(95 %)
13 diff
(98.3 %id)
CB118683 Liver .b 2732 to 3314 1 to 583       583/583
(100 %)
0 diff
(100 %id)
R29397   .b 2758 to 3057 1 to 299       299/300
(99 %)
3 diff
(99.0 %id)
BU608669 Human Lung Epithelial cells, lung .b 2781 to 3179 722 to 328   AAA   393/709
(55 %)
8 diff
(98.9 %id)
CX757859 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2805 to 3486 1 to 678     Submitted on the opposite strand 678/836
(81 %)
10 diff
(98.9 %id)
BG484887 lung .b 2882 to 3670 1 to 793       793/793
(100 %)
13 diff
(98.4 %id)
AB040359 testis_normal .b 2915 to 3285 1 to 371       371/387
(95 %)
6 diff
(98.5 %id)
CD357979 Pooled-Skin .b 2926 to 3682 1 to 766       766/774
(98 %)
29 diff
(96.3 %id)
TI_1948218107   .b 3096 to 3697 723 to 122   fully sequenced,   602/723
(83 %)
1 diff
(99.9 %id)
TI_1948218275   .b 3096 to 3697 724 to 123   fully sequenced,   602/724
(83 %)
1 diff
(99.9 %id)
BE748703 bone marrow, from acute myelogenous leukemia .b 3116 to 3812 701 to 1       701/734
(95 %)
15 diff
(98.0 %id)
CX866989 embryonic stem .b 3144 to 3987 1 to 844       844/844
(100 %)
1 diff
(99.9 %id)
TI_149295293   .b 3173 to 3885 796 to 83   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 713/968
(73 %)
16 diff
(98.4 %id)
CR736999 liver and spleen .b 3179 to 3915 1 to 738       738/738
(100 %)
1 diff
(99.9 %id)
TI_1948218448   .b 3207 to 3697 610 to 120   fully sequenced,   491/610
(80 %)
1 diff
(99.9 %id)
TI_1948218613   .b 3207 to 3697 613 to 123   fully sequenced,   491/613
(80 %)
1 diff
(99.9 %id)
BG533631 Liver .b 3210 to 3902 1 to 693       693/695
(99 %)
12 diff
(98.3 %id)
BF695445 brain, primitive neuroectoderm .b 3211 to 3907 1 to 694       694/861
(80 %)
24 diff
(97.3 %id)
BM985393 lung .b 3305 to 3885 597 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 581/581
(100 %)
2 diff
(99.7 %id)
BE044503 pooled .b 3364 to 3887 525 to 2       524/525
(99 %)
0 diff
(100 %id)
AI243780 pooled .b 3393 to 3882 492 to 3       490/492
(99 %)
0 diff
(100 %id)
BF110437 carcinoid, lung .b 3393 to 3882 493 to 4       490/493
(99 %)
0 diff
(100 %id)
BE467727 carcinoid, lung .b 3394 to 3881 488 to 1       488/488
(100 %)
0 diff
(100 %id)
EL946667 eyeball .b 3416 to 3582 1 to 168       168/168
(100 %)
5 diff
(97.1 %id)
BF110310 carcinoid, lung .b 3417 to 3882 469 to 4       466/469
(99 %)
0 diff
(100 %id)
BM931796 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3441 to 3862 1 to 422       422/426
(99 %)
1 diff
(99.8 %id)
BQ189100 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3441 to 3862 1 to 421       421/425
(99 %)
2 diff
(99.6 %id)
TI_151733558   .b 3441 to 3862 481 to 60       422/1077
(39 %)
0 diff
(100 %id)
BF111146 carcinoid, lung .b 3442 to 3882 444 to 4       441/444
(99 %)
1 diff
(99.8 %id)
AW006585 Prostate .b 3448 to 3885 438 to 1       438/438
(100 %)
3 diff
(99.4 %id)
BE673399 Prostate .b 3448 to 3885 438 to 1       438/438
(100 %)
0 diff
(100 %id)
AW291113   .b 3475 to 3885 426 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 411/411
(100 %)
0 diff
(100 %id)
TI_149301708   .b 3487 to 4364 963 to 88   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 876/954
(91 %)
5 diff
(99.5 %id)
CN400225 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 3491 to 4233 1 to 743       743/743
(100 %)
1 diff
(99.9 %id)
BG616240 embryonal carcinoma, testis .b 3493 to 4106 1 to 612       612/614
(99 %)
3 diff
(99.6 %id)
AA034931.
matches multiple genes
uterus .b 3500 to 3780 1 to 281     also hits gene BAG3 281/281
(100 %)
2 diff
(99.3 %id)
TI_149287151   .b 3507 to 4364 914 to 59   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 856/1124
(76 %)
16 diff
(98.6 %id)
FN096790 breast carcinoma .b 3513 to 3609 100 to 1     Submitted on the opposite strand 100/100
(100 %)
3 diff
(97.0 %id)
CB858039 anterior tongue, pooled .b 3537 to 3881 1 to 345   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 345/345
(100 %)
0 diff
(100 %id)
H54753 liver and spleen .b 3544 to 3977 1 to 437   fully sequenced,   437/437
(100 %)
8 diff
(98.2 %id)
BX094058 liver and spleen .b 3547 to 4162 1 to 616       616/622
(99 %)
2 diff
(99.7 %id)
AA429102 ovarian tumor, ovary .b 3566 to 3989 1 to 423       423/423
(100 %)
1 diff
(99.8 %id)
BU685185 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 3601 to 4364 782 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 764/764
(100 %)
0 diff
(100 %id)
AI474550 Prostate .b 3633 to 3885 253 to 1       253/253
(100 %)
0 diff
(100 %id)
BU854126 testis .b 3685 to 4282 1 to 612       612/720
(85 %)
20 diff
(97.3 %id)
AI221865 pooled .b 3686 to 3887 203 to 2       202/203
(99 %)
0 diff
(100 %id)
BM972521 lung .b 3704 to 4364 677 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 659/659
(100 %)
5 diff
(99.3 %id)
T54735 fetal spleen, Spleen .b 3771 to 4078 1 to 312   fully sequenced,   312/312
(100 %)
7 diff
(97.8 %id)
BQ581993 insulinoma, Pancreas .b 3783 to 4368 607 to 22     Submitted on the opposite strand 586/607
(96 %)
0 diff
(100 %id)
BU788211 insulinoma, Pancreas .b 3789 to 4368 601 to 22     Submitted on the opposite strand 580/601
(96 %)
0 diff
(100 %id)
BU783368 insulinoma, Pancreas .b 3793 to 4368 597 to 22     Submitted on the opposite strand 576/597
(96 %)
0 diff
(100 %id)
DN911819   .b 3801 to 4361 564 to 4       561/564
(99 %)
0 diff
(100 %id)
DN916329   .b 3811 to 4361 553 to 4       550/553
(99 %)
0 diff
(100 %id)
BG025958 Bone, osteosarcoma, cell line .b 3822 to 4375 1 to 553   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 553/553
(100 %)
1 diff
(99.9 %id)
H38576 liver and spleen .b 3832 to 4077 246 to 1       246/251
(98 %)
5 diff
(98.1 %id)
BP395178 pancreatic islet .b 3838 to 4328 1 to 491     Submitted on the opposite strand 491/495
(99 %)
5 diff
(99.0 %id)
BF346011 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3865 to 4364 78 to 573   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 496/573
(86 %)
6 diff
(99.0 %id)
AI400587 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3867 to 4381 515 to 1       515/515
(100 %)
0 diff
(100 %id)
BF115634 brain, glioblastoma (pooled) .b 3867 to 4357 491 to 1       491/491
(100 %)
0 diff
(100 %id)
BQ012105 placenta .b 3871 to 4368 512 to 15       498/512
(97 %)
0 diff
(100 %id)
AW172434 pooled .b 3910 to 4364 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
AI652430 pooled germ cell tumors .b 3913 to 4362 458 to 9       450/458
(98 %)
0 diff
(100 %id)
AI806064 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3931 to 4381 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI142808 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3936 to 4381 446 to 1       446/446
(100 %)
0 diff
(100 %id)
H54754 liver and spleen .b 3947 to 4077 131 to 1   fully sequenced,   131/131
(100 %)
0 diff
(100 %id)
AI630867 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3957 to 4368 412 to 1       412/412
(100 %)
0 diff
(100 %id)
TI_157597885   .b 3957 to 4368 506 to 92       415/647
(64 %)
0 diff
(100 %id)
AI613107 Kidney .b 3963 to 4364 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AA034923.
matches multiple genes
uterus .b 3966 to 4381 419 to 1     also hits gene ITPR1 419/420
(99 %)
6 diff
(98.6 %id)
AI688069 pooled .b 3977 to 4368 393 to 2       392/393
(99 %)
0 diff
(100 %id)
BF108893 pooled .b 3996 to 4368 371 to 3       369/371
(99 %)
0 diff
(100 %id)
T54649 fetal spleen, Spleen .b 4048 to 4365 329 to 1   fully sequenced,   329/329
(100 %)
9 diff
(97.3 %id)
BI089162 cervix .b 4179 to 4368 1 to 190       190/202
(94 %)
1 diff
(99.6 %id)
AJ583433 testis .c 1 to 3715 1 to 3715 D140E E630G I680T R730K tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 3715/3715
(100 %)
5 diff
(99.9 %id)
AI621072 pooled germ cell tumors .c 1976 to 2465 490 to 1       490/493
(99 %)
0 diff
(100 %id)
AI621096 pooled germ cell tumors .c 1978 to 2465 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BF223888 pooled germ cell tumors .c 2060 to 2465 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AK096205   .d 1 to 2440 1 to 2440 E637K tiling clone, available from FLJ,   2440/2440
(100 %)
1 diff
(100.0 %id)
DA661081   .d 2 to 575 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB046430 testis .d 101 to 659 17 to 577   capped   561/576
(97 %)
8 diff
(98.7 %id)
BG182476   .d 103 to 501 1 to 399       399/399
(100 %)
1 diff
(99.8 %id)
DB321901   .d 1971 to 2440 470 to 1       470/472
(99 %)
0 diff
(100 %id)
DA177690 amygdala .e 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
BM012859 brain, neuroblastoma, cell line .e 14 to 709 1 to 736       581/742
(78 %)
36 diff
(95.2 %id)
AU253998 neuroblastoma .e 32 to 715 1 to 674   tiling clone,   674/674
(100 %)
15 diff
(97.8 %id)
AU253999 neuroblastoma .e 1660 to 2358 700 to 1   tiling clone,   700/700
(100 %)
10 diff
(98.6 %id)
AK127108 brain .f 1 to 3982 1 to 3982 exact tiling clone, available from FLJ,   3982/3982
(100 %)
2 diff
(100.0 %id)
AI633072 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 1042 to 1358 17 to 333     Submitted on the opposite strand 317/342
(92 %)
6 diff
(98.3 %id)
BE669674 carcinoid, lung .f 3521 to 4001 481 to 1   tiling clone,   481/481
(100 %)
1 diff
(99.8 %id)
AI254462 ovary, papillary serous carcinoma .f 3870 to 4000 10 to 140   AAA Submitted on the opposite strand 131/140
(93 %)
9 diff
(93.6 %id)
AI251255 ovary, papillary serous carcinoma .f 3870 to 3992 10 to 132   AAA Submitted on the opposite strand 123/132
(93 %)
6 diff
(95.5 %id)
CN285231 embryonic stem cells, cell lines H1, H7, andH9 .g 1 to 628 1 to 628   tiling clone,   628/628
(100 %)
3 diff
(99.6 %id)
AA310560   .g 864 to 1168 1 to 307   tiling clone,   307/307
(100 %)
2 diff
(99.4 %id)
AK308372 kidney, tumor tissue .h 1 to 1457 1 to 1458 N147K V148M I149* tiling clone,   1456/1458
(99 %)
5 diff
(99.7 %id)
DC411945 kidney, tumor tissue .h 1 to 602 1 to 602       602/602
(100 %)
0 diff
(100 %id)
DB030075 testis .i 1 to 592 2 to 593   tiling clone, capped   592/592
(100 %)
1 diff
(99.9 %id)
DB040423 testis .i 103 to 670 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
DB336946 testis .i 1509 to 2017 509 to 1   tiling clone,   509/511
(99 %)
0 diff
(100 %id)
CA311307 Human Lung Epithelial cells, lung .j-u 1 to 687 687 to 1   tiling clone,   687/687
(100 %)
1 diff
(99.9 %id)
AV722099 hypothalamus .j-u 3 to 676 674 to 1   tiling clone, Submitted on the opposite strand 674/684
(98 %)
2 diff
(99.8 %id)
AV722877 hypothalamus .j-u 96 to 682 631 to 54     Submitted on the opposite strand 578/635
(91 %)
0 diff
(100 %id)
AW514772 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j-u 237 to 675 439 to 1       439/439
(100 %)
0 diff
(100 %id)
AV722930 hypothalamus .j-u 282 to 682 425 to 29     Submitted on the opposite strand 397/434
(91 %)
0 diff
(100 %id)
BE504363 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .j-u 353 to 673 321 to 1       321/321
(100 %)
3 diff
(99.1 %id)
BX101576 carcinoid, lung .j-u 538 to 961 1 to 424   tiling clone, AAA   424/424
(100 %)
0 diff
(100 %id)
AA282987 germinal center B cell .j-u 546 to 912 11 to 378     Submitted on the opposite strand 368/378
(97 %)
6 diff
(98.5 %id)
AI887840 carcinoid, lung .j-u 569 to 964 396 to 1       396/396
(100 %)
2 diff
(99.5 %id)
Z43473 brain, total brain .j-u 938 to 1311 1 to 374   tiling clone, to resequence,   374/374
(100 %)
0 diff
(100 %id)
FN046281 breast carcinoma .j-u 1062 to 1134 1 to 73       73/74
(98 %)
1 diff
(98.7 %id)
Z39549 brain, total brain .j-u 1911 to 2244 334 to 1   tiling clone, to resequence,   334/334
(100 %)
0 diff
(100 %id)
BM914827 amelanotic melanoma, cell line, skin .k 1 to 744 1 to 750 exact tiling clone,   750/1116
(67 %)
14 diff
(98.8 %id)
CN401192 embryonic stem cells, cell lines H1, H7, andH9 .l 1 to 640 1 to 639 Q2A tiling clone,   639/639
(100 %)
1 diff
(99.9 %id)
DA148368 amygdala .m 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
BM744376 Ascites, stomach .n 1 to 558 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM766811 Ascites, stomach .n 1 to 452 1 to 452       452/452
(100 %)
1 diff
(99.8 %id)
BM767347 Ascites, stomach .n 1 to 725 1 to 725 exact tiling clone,   725/725
(100 %)
0 diff
(100 %id)
BM770312 Ascites, stomach .n 1 to 539 1 to 539       539/539
(100 %)
8 diff
(98.6 %id)
BM770406 Ascites, stomach .n 1 to 520 1 to 520       520/520
(100 %)
1 diff
(99.9 %id)
BM770928 Ascites, stomach .n 1 to 509 1 to 509       509/509
(100 %)
0 diff
(100 %id)
BM771016 Ascites, stomach .n 1 to 506 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BM742557 Ascites, stomach .n 20 to 448 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
DA861423 placenta .o 1 to 520 2 to 521 exact tiling clone, capped   520/520
(100 %)
0 diff
(100 %id)
BQ573925 Chondrosarcoma Grade II, Left Pelvis .p 1 to 612 629 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 611/611
(100 %)
7 diff
(98.9 %id)
TI_154107977   .p 495 to 1449 1006 to 67   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 940/972
(96 %)
26 diff
(97.4 %id)
CR739926 germinal center B cell .p 583 to 1302 717 to 1   tiling clone, Submitted on the opposite strand 717/717
(100 %)
3 diff
(99.6 %id)
CA447290 Chondrosarcoma, Left Pelvis .p 685 to 1449 783 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 765/765
(100 %)
3 diff
(99.7 %id)
W56390 parathyroid gland, parathyroid tumor .p 738 to 1242 1 to 518       518/521
(99 %)
15 diff
(97.2 %id)
AA283157 germinal center B cell .p 830 to 1268 435 to 1     Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
AI031812 parathyroid gland, parathyroid tumor .p 949 to 1450 509 to 8       502/509
(98 %)
0 diff
(100 %id)
AI342873 carcinoid, lung .p 1024 to 1450 430 to 4   tiling clone,   427/430
(99 %)
0 diff
(100 %id)
AW451189   .p 1047 to 1449 420 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 403/403
(100 %)
0 diff
(100 %id)
AI222207 pooled .p 1093 to 1450 360 to 3       358/360
(99 %)
0 diff
(100 %id)
BI050692 placenta_normal .p 1164 to 1448 286 to 1       286/286
(100 %)
3 diff
(99.0 %id)
AI873597 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .p 1250 to 1449 200 to 1       200/200
(100 %)
1 diff
(99.5 %id)
DA825463 pericardium .q 1 to 511 2 to 512 G26E N27I K28N Q29R M30C ... tiling clone, to resequence, capped   511/511
(100 %)
2 diff
(99.7 %id)
DB327932 pericardium .q 1258 to 1799 542 to 1   tiling clone, to resequence,   542/542
(100 %)
0 diff
(100 %id)
BU561306 testis .r 1 to 718 1 to 729 exact tiling clone,   729/834
(87 %)
16 diff
(98.1 %id)
CV398441 breast .r 195 to 822 10 to 637       628/637
(98 %)
6 diff
(99.1 %id)
BE072287 breast .r 332 to 866 538 to 5   tiling clone, Submitted on the opposite strand 534/538
(99 %)
0 diff
(100 %id)
DW415412 Liver .r 817 to 1005 17 to 205   tiling clone,   273/313
(87 %)
20 diff
(93.7 %id)
DA800292 brain .s 1 to 567 2 to 567   tiling clone, capped   566/568
(99 %)
4 diff
(99.3 %id)
BX472098   .s 461 to 952 1 to 492   tiling clone,   492/492
(100 %)
1 diff
(99.8 %id)
DB128463 thymus .u 1 to 568 2 to 569 V68G P71S tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
DA795295 brain .va 1 to 565 2 to 565 exact tiling clone, capped   564/567
(99 %)
5 diff
(99.2 %id)
DW411134 Liver .va 56 to 368 18 to 330       313/330
(94 %)
6 diff
(98.2 %id)
DW426634 Liver .va 56 to 319 18 to 281       264/281
(93 %)
6 diff
(97.9 %id)
BQ186444 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb-u 1 to 506 1 to 507 exact     507/507
(100 %)
1 diff
(99.9 %id)
BQ185859 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb-u 1 to 506 1 to 506 exact     506/506
(100 %)
0 diff
(100 %id)
TI_151730487   .vb-u 1 to 518 560 to 43 exact tiling clone,   518/1065
(48 %)
0 diff
(100 %id)
TI_151730062   .vb-u 1 to 518 562 to 45 exact     518/1057
(49 %)
0 diff
(100 %id)
BX101720 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vc-u 1 to 449 463 to 15 exact tiling clone, AAA Submitted on the opposite strand 449/449
(100 %)
0 diff
(100 %id)
AI933671 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .vc-u 82 to 449 371 to 1       371/371
(100 %)
3 diff
(99.2 %id)
AA759354   .vc-u 105 to 451 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AA883157 pooled .vc-u 130 to 452 323 to 1   tiling clone,   323/323
(100 %)
0 diff
(100 %id)
AA360836   .vd-u 1 to 296 1 to 296 E9D tiling clone,   296/296
(100 %)
1 diff
(99.7 %id)
DA373043 thalamus Gene CSPP1, variant not shown       capped      
CN400226 embryonic stem cells, DMSO-treated H9 cellline Gene CSPP1, variant not shown         Suspected internal deletion, this clone was ignored    
BG116891 duodenal adenocarcinoma, cell line, small intestine Gene CSPP1, variant not shown         Suspected internal deletion, this clone was ignored    
CB960751 Human Placenta, placenta Gene CSPP1, variant not shown              
DA955632 Spleen Gene CSPP1, variant not shown       capped      
DB333990 Spleen Gene CSPP1, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb-u, .vc-u, .vd-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C